Pharma

Your Article Summary

See Latest Articles

Approval of Partial Change of API Manufacturing Method and Pharmaceutical Formulation of the Recombinant Human Erythropoietin "Epogin Injection"
Chugai Pharmaceutical Co., 06/29/09

Chugai Pharmaceutical Co., Ltd. announced that the company has acquired the approval for the partial change of the API manufacturing method and the pharmaceutical formulation of a recombinant human erythropoietin from the Japanese Ministry of Health, Labour and Welfare on April.

Today in Drug/Product Approvals...keeping you current

Receive free subspecialty "5-minute updates" via email

Human genome sciences announces submission of marketing authorization application to emea for joulferon
Human Genome Sciences, 12/15/09

Mylan Receives Approval for Generic Version of Antiepileptic Keppra 1000 mg
Mylan, 12/15/09

FDA Advisory Committee Supports Use of Aztreonam for Inhalation Solution for Patients with Cystic Fibrosis
Gilead, 12/14/09

 See all of Drug/Product Approvals